|
|
ChanTest sets the standard in preclinical cardiac risk assessment
At ChanTest, we work closely with customers worldwide to design a testing program that meets their drug safety, regulatory, and budgetary goals. Then, we use the latest screening techniques and proprietary assays to deliver fast, accurate, and reliable results. We don’t just deliver raw data – our ion channel experts tell you what the results mean! Count on ChanTest. Our Good Laboratory Practice (GLP)-safety assays have been validated by the US Food and Drug Administration (FDA) and more than 140 sponsors. And ChanTest provides 95 percent confidence limits on GLP IC50 studies, with study-to-study variations of 1.1 to 1.9.
Our customers benefit from our work with the FDA and others in the clinical-research and regulatory arenas, and from our 25+ years of ion channel research in various therapeutic targets. ChanTest always remains ahead of the curve on the latest ion channel research, new areas of interest for regulators, and upcoming regulatory requirements. We recognize that you need to receive results quickly, so we focus on delivering accurate results in as few as one to four weeks, depending on study complexity.
|
|
|
|